Nevertheless, fetuin-A predicts progression of liver and vascular fibrosis in hemodynamically stable patients with cardiovascular disease and nonalcoholic fatty liver disease [161]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.